212 related articles for article (PubMed ID: 14522371)
1. Mismatch repair and response to DNA-damaging antitumour therapies.
Bignami M; Casorelli I; Karran P
Eur J Cancer; 2003 Oct; 39(15):2142-9. PubMed ID: 14522371
[TBL] [Abstract][Full Text] [Related]
2. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
3. DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias.
Casorelli I; Bossa C; Bignami M
Int J Environ Res Public Health; 2012 Aug; 9(8):2636-57. PubMed ID: 23066388
[TBL] [Abstract][Full Text] [Related]
4. DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents.
Pors K; Patterson LH
Curr Top Med Chem; 2005; 5(12):1133-49. PubMed ID: 16248788
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of tolerance to DNA damaging therapeutic drugs.
Karran P
Carcinogenesis; 2001 Dec; 22(12):1931-7. PubMed ID: 11751422
[TBL] [Abstract][Full Text] [Related]
6. Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin.
Vernole P; Tedeschi B; Tentori L; Levati L; Argentin G; Cicchetti R; Forini O; Graziani G; D'Atri S
Mutat Res; 2006 Feb; 594(1-2):63-77. PubMed ID: 16139849
[TBL] [Abstract][Full Text] [Related]
7. Mismatch repair proficiency and in vitro response to 5-fluorouracil.
Carethers JM; Chauhan DP; Fink D; Nebel S; Bresalier RS; Howell SB; Boland CR
Gastroenterology; 1999 Jul; 117(1):123-31. PubMed ID: 10381918
[TBL] [Abstract][Full Text] [Related]
8. DNA repair: a double-edged sword.
Wei Q; Frazier ML; Levin B
J Natl Cancer Inst; 2000 Mar; 92(6):440-1. PubMed ID: 10716953
[No Abstract] [Full Text] [Related]
9. Signalling cell cycle arrest and cell death through the MMR System.
O'Brien V; Brown R
Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
[TBL] [Abstract][Full Text] [Related]
10. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
[TBL] [Abstract][Full Text] [Related]
11. Human mismatch repair, drug-induced DNA damage, and secondary cancer.
Karran P; Offman J; Bignami M
Biochimie; 2003 Nov; 85(11):1149-60. PubMed ID: 14726020
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the DNA mismatch repair system in antineoplastic drug resistance.
Lage H; Dietel M
J Cancer Res Clin Oncol; 1999; 125(3-4):156-65. PubMed ID: 10235469
[TBL] [Abstract][Full Text] [Related]
13. Thiopurines, DNA damage, DNA repair and therapy-related cancer.
Karran P
Br Med Bull; 2006; 79-80():153-70. PubMed ID: 17277075
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage.
Aquilina G; Crescenzi M; Bignami M
Carcinogenesis; 1999 Dec; 20(12):2317-26. PubMed ID: 10590226
[TBL] [Abstract][Full Text] [Related]
15. Different effects of methotrexate on DNA mismatch repair proficient and deficient cells.
Frouin I; Prosperi E; Denegri M; Negri C; Donzelli M; Rossi L; Riva F; Stefanini M; Scovassi AI
Eur J Cancer; 2001 Jun; 37(9):1173-80. PubMed ID: 11378349
[TBL] [Abstract][Full Text] [Related]
16. Cellular physiology of mismatch repair.
Wu X; Khalpey Z; Cascalho M
Curr Pharm Des; 2004; 10(32):4121-6. PubMed ID: 15579092
[TBL] [Abstract][Full Text] [Related]
17. Platinum resistance: the role of DNA repair pathways.
Martin LP; Hamilton TC; Schilder RJ
Clin Cancer Res; 2008 Mar; 14(5):1291-5. PubMed ID: 18316546
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
[TBL] [Abstract][Full Text] [Related]
19. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).
Fedier A; Fink D
Int J Oncol; 2004 Apr; 24(4):1039-47. PubMed ID: 15010846
[TBL] [Abstract][Full Text] [Related]
20. p53 interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxide.
Lin X; Ramamurthi K; Mishima M; Kondo A; Howell SB
Mol Pharmacol; 2000 Dec; 58(6):1222-9. PubMed ID: 11093757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
